BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30887553)

  • 1. Randomised trials with provision for early stopping for benefit (or harm): The impact on the estimated treatment effect.
    Walter SD; Guyatt GH; Bassler D; Briel M; Ramsay T; Han HD
    Stat Med; 2019 Jun; 38(14):2524-2543. PubMed ID: 30887553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility.
    Walter SD; Han H; Briel M; Guyatt GH
    Stat Med; 2017 Apr; 36(9):1506-1518. PubMed ID: 28183155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying over-estimation in early stopped clinical trials and the "freezing effect" on subsequent research.
    Wang H; Rosner GL; Goodman SN
    Clin Trials; 2016 Dec; 13(6):621-631. PubMed ID: 27271682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic survey of randomised trials that stopped early for reasons of futility.
    Walter SD; Han H; Guyatt GH; Bassler D; Bhatnagar N; Gloy V; Schandelmaier S; Briel M
    BMC Med Res Methodol; 2020 Jan; 20(1):10. PubMed ID: 31948397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trials stopped early for benefit: a systematic review.
    Montori VM; Devereaux PJ; Adhikari NK; Burns KE; Eggert CH; Briel M; Lacchetti C; Leung TW; Darling E; Bryant DM; Bucher HC; Schünemann HJ; Meade MO; Cook DJ; Erwin PJ; Sood A; Sood R; Lo B; Thompson CA; Zhou Q; Mills E; Guyatt GH
    JAMA; 2005 Nov; 294(17):2203-9. PubMed ID: 16264162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of protocols and publications suggested that most discontinuations of clinical trials were not based on preplanned interim analyses or stopping rules.
    Stegert M; Kasenda B; von Elm E; You JJ; Blümle A; Tomonaga Y; Saccilotto R; Amstutz A; Bengough T; Briel M;
    J Clin Epidemiol; 2016 Jan; 69():152-60. PubMed ID: 26361993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity analyses assessing the impact of early stopping on systematic reviews: Recommendations for interpreting guidelines.
    Marschner IC; Askie LM; Schou IM
    Res Synth Methods; 2020 Mar; 11(2):287-300. PubMed ID: 31901013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome.
    Choodari-Oskooei B; Parmar MK; Royston P; Bowden J
    Trials; 2013 Jan; 14():23. PubMed ID: 23343147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dangers of stopping a trial too early.
    Briel M; Bassler D; Wang AT; Guyatt GH; Montori VM
    J Bone Joint Surg Am; 2012 Jul; 94 Suppl 1():56-60. PubMed ID: 22810449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the impact of efficacy stopping rules on the error rates under the multi-arm multi-stage framework.
    Blenkinsop A; Parmar MK; Choodari-Oskooei B
    Clin Trials; 2019 Apr; 16(2):132-141. PubMed ID: 30648428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2).
    Briel M; Lane M; Montori VM; Bassler D; Glasziou P; Malaga G; Akl EA; Ferreira-Gonzalez I; Alonso-Coello P; Urrutia G; Kunz R; Culebro CR; da Silva SA; Flynn DN; Elamin MB; Strahm B; Murad MH; Djulbegovic B; Adhikari NK; Mills EJ; Gwadry-Sridhar F; Kirpalani H; Soares HP; Abu Elnour NO; You JJ; Karanicolas PJ; Bucher HC; Lampropulos JF; Nordmann AJ; Burns KE; Mulla SM; Raatz H; Sood A; Kaur J; Bankhead CR; Mullan RJ; Nerenberg KA; Vandvik PO; Coto-Yglesias F; Schünemann H; Tuche F; Chrispim PP; Cook DJ; Lutz K; Ribic CM; Vale N; Erwin PJ; Perera R; Zhou Q; Heels-Ansdell D; Ramsay T; Walter SD; Guyatt GH
    Trials; 2009 Jul; 10():49. PubMed ID: 19580665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stopping clinical trials early for benefit: impact on estimation.
    Freidlin B; Korn EL
    Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overestimation of benefit when clinical trials stop early: a simulation study.
    Liu S; Garrison SR
    Trials; 2022 Sep; 23(1):747. PubMed ID: 36064448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of clinical trials with early stopping: an investigation of potential bias.
    Schou IM; Marschner IC
    Stat Med; 2013 Dec; 32(28):4859-74. PubMed ID: 23824994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Operating characteristics of sample size re-estimation with futility stopping based on conditional power.
    Lachin JM
    Stat Med; 2006 Oct; 25(19):3348-65. PubMed ID: 16345019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underestimation of treatment effects in sequentially monitored clinical trials that did not stop early for benefit.
    Marschner IC; Schou IM
    Stat Methods Med Res; 2019; 28(10-11):3027-3041. PubMed ID: 30132370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stopping a trial early - and then what?
    Wittes J
    Clin Trials; 2012 Dec; 9(6):714-20. PubMed ID: 22879573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis.
    Bassler D; Briel M; Montori VM; Lane M; Glasziou P; Zhou Q; Heels-Ansdell D; Walter SD; Guyatt GH; ; Flynn DN; Elamin MB; Murad MH; Abu Elnour NO; Lampropulos JF; Sood A; Mullan RJ; Erwin PJ; Bankhead CR; Perera R; Ruiz Culebro C; You JJ; Mulla SM; Kaur J; Nerenberg KA; Schünemann H; Cook DJ; Lutz K; Ribic CM; Vale N; Malaga G; Akl EA; Ferreira-Gonzalez I; Alonso-Coello P; Urrutia G; Kunz R; Bucher HC; Nordmann AJ; Raatz H; da Silva SA; Tuche F; Strahm B; Djulbegovic B; Adhikari NK; Mills EJ; Gwadry-Sridhar F; Kirpalani H; Soares HP; Karanicolas PJ; Burns KE; Vandvik PO; Coto-Yglesias F; Chrispim PP; Ramsay T
    JAMA; 2010 Mar; 303(12):1180-7. PubMed ID: 20332404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stopping rules and estimation problems in clinical trials.
    Hughes MD; Pocock SJ
    Stat Med; 1988 Dec; 7(12):1231-42. PubMed ID: 3231947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trials addressing a similar question are commonly published after a trial stopped early for benefit.
    Murad MH; Guyatt GH; Domecq JP; Vernooij RWM; Erwin PJ; Meerpohl JJ; Prutsky GJ; Akl EA; Mueller K; Bassler D; Schandelmaier S; Walter SD; Busse JW; Kasenda B; Pagano G; Pardo-Hernandez H; Montori VM; Wang Z; Briel M
    J Clin Epidemiol; 2017 Feb; 82():12-19. PubMed ID: 27832953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.